Financials
April 30, 2018 / 12:58 PM / in 10 months

BRIEF-Attenua, A Clinical-Stage Biopharma Company, Says Announced Completion Of $35 Million Series A Financing

1 Min Read

April 30 (Reuters) - ATTENUA:

* ATTENUA, A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, SAYS ANNOUNCED COMPLETION OF $35 MILLION SERIES A FINANCING Source text for Eikon: (Reuters.Briefs@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below